Search Results - "Coulie, P.G."

About human tumor antigens to be used in immunotherapy by Lucas, S, Coulie, P.G

“…Abstract The choice of antigens to be used in cancer immunotherapy remains a crucial and difficult issue. This review highlights some properties of the…”
Get full text

Characterization of T cells during BCG therapy for NMIBC by Brochier, W., Van Baren, N., Somerhausen, A-E., Hames, G., Dauguet, N., Dano, H., Tombal, B., Coulie, P.G.

Get full text

Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery by Forget, P., Bentin, C., Machiels, J.-P., Berliere, M., Coulie, P.G., De Kock, M.

“…An association between the use of non-steroidal anti-inflammatory drugs (NSAIDs) and better outcome after mastectomy and lung surgery for cancer has been…”
Get full text

A phase Ib/II study of durvalumab combined with dose-dense EC in neoadjuvant setting for patients with locally advanced luminal B HER2(-) or triple negative breast cancers (B-IMMUNE) by Devaux, A., Canon, J.-L., Duhoux, F.P., Delrée, P., Galant, C., Coulie, P.G., Bar, I., Constant, M., Haussy, S., Bricard, O., Missault, K., Berlière, M., Willems, T., Carrasco, J.

Get full text

Presence of tumor-specific cytolytic T cells in human primary breast carcinoma: consequences for immunotherapy by Schröder, D., Carrasco, J., Bricard, O., Hames, G., Remy, N., Missault, K., Canon, J.-L., Vannuffel, P., Galant, C., Berlière, M., Coulie, P.G.

Get full text

Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM Workshop by Houot, Roch, Gaulard, Philippe, Schreiber, Robert, Mellman, Ira, Lambotte, Olivier, Coulie, Pierre G, Fest, Thierry, Korman, Alan, Levy, Ronald, Shipp, Margaret, Tarte, Karin, Kohrt, Holbrook, Marabelle, Aurélien, Ansell, Stephen, Watier, Hervé, van Elsas, Andrea, Balakumaran, Arun, Arce Vargas, Frederick, Quezada, Sergio A, Salles, Gilles, Olive, Daniel

“…In November 2015, the CALYM Carnot Institute held a 2-d workshop to discuss the current and future development of immunomodulatory antibodies for the treatment…”
Get full text

GeniusVac-Mel 4, essai de phase 1 utilisant un vaccin basé sur une lignée de cellules dendritiques plasmocytoïdes dans le traitement du mélanome métastatique by Charles, J., Chaperot, L., Hannani, D., Bruder Costa, J., Templier, I., Trabelsi, S., Gil, H., Moisan, A., Persoons, V., Hegelhofer, H., Schir, E., Quesada, J.-L., Mendoza, C., Mouret, S., Aspord, C., Manches, O., Coulie, P.G., Khammari, A., Dreno, B., Leccia, M.T., Plumas, J.

“…Le développement de vaccins anti-tumoraux est une approche prometteuse dans le traitement du mélanome notamment en combinaison avec les inhibiteurs de points…”
Get full text

Monitoring CTL responses in melanoma patients vaccinated with MAGE antigenic peptides by Boon, T., Karanikas, V., Demoitié, M.-A., Lurquin, C., Brichard, V., van Baren, N., Coulie, P.G.

Get full text

Clustered organization of homologous KRAB zinc‐finger genes with enhanced expression in human T lymphoid cells by Bellefroid, E.J., Marine, J.C., Ried, T., Lecocq, P.J., Rivière, M., Amemiya, C., Poncelet, D.A., Coulie, P.G., Jong, P., Szpirer, C.

“…KRAB zinc‐finger proteins (KRAB‐ZFPs) constitute a large subfamily of ZFPs of the Krüppel C2H2 type. KRAB (Krüppel‐associated box) is an evolutionarily…”
Get full text

Tumour specific antigens: Perspectives for vaccination by Coulie, P.G., Van der Bruggen, P., Van den Eynde, B., Marchand, M., Boon, T.

Get full text

572 Production of cytolytic T cell (CTL) clones directed against autologous small cell and non-small cell lung cancer cell lines by Weynants, P., Marchand, M., Baurain, J.F., Deloos, M., Boon, T., Coulie, P.G.

Get full text

995 Genes coding for tumor rejection antigens by Boon, T., Van Der Bruggen, P., Brichard, V., Van Pel, A., Coulie, P.G., Gaugler, B., Van Den Eynde, B., De Plaen, E.

“…We have isolated a number of genes that code for antigens recognized on human melanomas by autologous cytolytic T cells (CTL). A gene named MAGE-1 codes for…”
Get full text

Differences in the recognition by CTL of peptides presented by the HLA-B4402 and the HLA-B4403 molecules which differ by a single amino acid by Herman, J., Jongeneel, V., Kuznetsov, D., Coulie, P.G.

“…The HLA‐B*4402 and B*4403 molecules differ only at residue 156, which borders the peptide binding site. Strong in vivo allogeneic reactions mediated by…”
Get full text

Correction of HLA-Cw0501 and identification of HLA-Cw0711 by Baurain, J.-F., Coulie, P.G.

“…We describe a new HLA‐C allele, Cw*0711, that differs from Cw*0704 by one residue in the intracytoplasmic region, and correct two errors in the published…”
Get full text